Neumora Therapeutics NMRA
NASDAQ NMRA
$0.47 +0.01 (+1.37%)
At close: Nov 11, 2026 · 4:00 PM EST

Neumora Therapeutics (NMRA) Capital Expenditures (2022 - 2023)

Updated

Neumora Therapeutics (NMRA) posted Capital Expenditures of $44,000 for Q4 2023, up 91.3% from $23,000 a year earlier and up 18.9% from the prior quarter.

Analysis

Neumora Therapeutics (NMRA) Capital Expenditures (2022 - 2023) Analysis & Trends

For FY2023, Neumora Therapeutics' Capital Expenditures came in at $117,000, down 77.1% from FY2022.

  • In prior years, Neumora Therapeutics' Capital Expenditures was $511,000 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Neumora Therapeutics 88.31 Mn -529.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 44,000.00
Sep 30, 2023 37,000.00
Mar 31, 2023 36,000.00
Dec 31, 2022 23,000.00
API Access

Neumora Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NMRA&period=max&api_key=YOUR_API_KEY